News

Massage therapy seems to benefit cancer patients


 

Massage therapy class

Photo courtesy of Barbara

E. Carver/New York College

of Health Professions

Massage therapy can reduce pain, fatigue, and anxiety in cancer patients, according to a review and meta-analysis published in Pain Medicine.

Massage therapy is commonly used among people seeking pain management, and research has generally supported its use.

However, there has been no published, rigorous review of the available research and evidence for massage therapy’s efficacy for pain populations, especially for cancer populations.

So Courtney Boyd, of the Samueli Institute in Alexandria, Virginia, and her colleagues set out to conduct just such a review.

The team assessed the quality of massage therapy research and evidence for its efficacy in treating pain, function-related quality of life, and health-related quality of life in cancer patients.

The researchers reviewed data from 12 high-quality studies and 4 low-quality studies.

The team said they could not assess health-related quality of life, emotional stress, or activity outcomes because too few of the studies examined these outcomes.

However, the data suggested that massage therapy can effectively reduce pain intensity or severity when compared to no treatment (standardized mean difference [SMD]=-0.20) or active comparators (SMD=-0.55).

Massage therapy also proved effective for reducing fatigue (SMD=-1.06) and anxiety (SMD=-1.24) when compared to active comparators.

Based on these results, the researchers concluded that massage therapy may have beneficial effects in cancer patients, so they should consider it as an option.

However, before definitive clinical conclusions and recommendations can be made at a policy level, specific factors surrounding the massage protocol, as well as selection of appropriate controls and standard outcomes, need to be well-understood.

Recommended Reading

Pretransplantation mogamulizumab for ATLL raises risk of GVHD
MDedge Hematology and Oncology
Drug granted breakthrough designation for BPDCN
MDedge Hematology and Oncology
Predicting outcomes in relapsed BCP-ALL
MDedge Hematology and Oncology
Music may alleviate cancer patients’ symptoms
MDedge Hematology and Oncology
Cancer survivors have ‘normal’ sex lives, survey says
MDedge Hematology and Oncology
Pulmonary complications affect cancer survivors long-term
MDedge Hematology and Oncology
Research provides new insight into CLL
MDedge Hematology and Oncology
Chemo during pregnancy may impact baby’s fertility
MDedge Hematology and Oncology
Venetoclax can produce short-term responses in AML
MDedge Hematology and Oncology
FDA approves drug for prevention of CINV
MDedge Hematology and Oncology